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Abstract: Rare disorders are defined as diseases, including those of genetic origin, which are life-threatening or chronically
debilitating, which are of such low prevalence that special combined efforts are needed to address them. We present a case with a
rare association between two genetic conditions: Turner phenotype and beta thalassemia minor. Turner syndrome is a chromosomal
disorder that is characterized by the absence of all or part of a second sex chromosome in some or all cells. This condition occurs in
1 in 2,500 to 3,000 girls. The physical features include webbing of the neck, short stature, delayed growth of the skeleton, broad
chest, cardivascular abnormalities and gonadal dysgenesis. Women with this disorder are usually infertile due to ovarian failure. The
clinical diagnosis was confirmed by the cytogenetic and by FISH analysis, which revealed the presence of only one X chromosome.
Treatment may include human growth hormone and estrogen replacement therapy. On the other hand, thalassemias are genetic
conditions that result from imbalance in the normal coordinated synthesis of the globin subunits that make up the hemoglobin
tetramer, leading to decreased and defective production of hemoglobin. Beta thalassemia syndromes are hereditary disorders
characterized by a genetic deficiency in the synthesis of beta-globin chains. ȕ thalassemia is inherited in an autosomal recessive
manner. Thalassemia minor usually presents as an asymptomatic mild microcytic anemia, but our case also had splenomegaly and
required splenectomy.
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INTRODUCTION
Rare disorders are defined as diseases, including
those of genetic origin, which are life-threatening or
chronically debilitating, which are of such low
prevalence that special combined efforts are needed to
address them. Genetic disorders are usually considered
to be rare diseases, thus for affected individuals and
their families, but also for their primary and specialty
care physicians, it is essential to recognize them and
provide the appropriate treatment and support. Some of
these conditions may recur again in families and may
cause medical and social problems. Genetic disorders
may be caused by changes in the structure or number
of the chromosomes or in the DNA.
Turner syndrome is among the most common sex
chromosomal aneuploidies, affecting 1/2500 - 1/3000
females. It results as the consequence of the absence of
one sex chromosome or part of an X chromosome in a
female, with only one normal X chromosome present
in the cell. It is estimated that 15/1000 of clinically
recognized pregnancies are 45,X and more than 99%
do not survive beyond 28 weeks of gestation.
The absence of a normal second sex chromosome
leads to a constellation of physical abnormalities, such
as  short  stature,  signs  of  ovarian  failure  and  skeletal
dysplasia. The typical findings in Turner syndrome
include congenital lymphedema, neck webbing, low
posterior hairline, short stature, gonadal dysgenesis and
often renal and cardiovascular anomalies. Prematurity
is common in pregnancies of infants with the disorder.
Growth velocity is less than normal, intrauterine
growth retardation and progressive decline in growth
velocity during childhood being frequently noticed.
Affected females have characteristic craniofacial
features, short and broad neck, pterygium coli, shield
chest with increased internipple distance, different
skeletal manifestations. Congenital heart defects are
estimated to occur in about 30% of the cases.
Autoimmune diseases, vascular anomalies or
genitourinary lesions were also associated with the
disorder [1].
Affected subjects have normal female external
genitalia, but because they lack functioning ovaries and
thus the estrogens produced by ovaries, neither breast
development, nor menstruation occurs spontaneously at
puberty, primary amenorrhea representing the main
reason to seek diagnosis. Progressive ovarian failure
and sterility or in some cases infertility are other
hallmarks of the disease.
Most individuals with Turner syndrome have
normal intellligence. Significantly higher verbal level
than performance level attributed to a specific space
form-perception deficit was described for many
teenagers with this condition [14].
Turner syndrome phenotype is highly variable and
there is not a single feature specific only for this
syndrome. That is why for the diagnosis of Turner
syndrome demonstration of the cytogenetic
abnormality is absolutely necessary [12].
The most frequent chromosome constitution in
Turner  syndrome  is  45,X  with  no  second  sex
chromosome, either X or Y. However, about 50 percent
of cases have other karyotypes. About one quarter of
Turner syndrome cases involve mosaic karyotypes
(45,X/46,XX), the others having deletions of the short
or long arm of the X chromosome, but ring
chromosomes or isochromosomes may also be seen.
Usually the single X is maternal in origin; in other
words, the meiotic error is usually paternal.
The number of detectable aberrations has increased
to several thousands during the last decades. When a
chromosomal abnormality is suspected, cytogenetic
analysis is the most common approach used for
detection. Methods involving application of
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but advances in molecular cytogenetics, especially the
technique of fluorescence in situ hybridization (FISH),
have allowed obtaining of more precise information
especially on chromosomal structure [6].
Thalassemia refers to a spectrum of diseases
characterized by reduced or absent production of one or
more globin chains. They are genetic conditions that
result from imbalance in the normal coordinated
synthesis  of  the  globin  subunits  that  make  up  the
hemoglobin tetramer, leading to the decreased and
defective production of hemoglobin. Hemoglobin is a
tetramer that consists of 2 pairs of globin chains. There
are two hemoglobin gene clusters involved in the
production of hemoglobin located at the end of the
short arm of chromosomes 16 and 11, respectively.
Their control is complex, including an upstream locus
control region on each of these chromosomes as well as
an X-linked control site [4].
Beta thalassemia syndromes are hereditary
disorders characterized by a genetic deficiency in the
synthesis of beta-globin chains. Beta thalassemia is
inherited in an autosomal recessive manner. Beta-
thalassemia minor refers to the heterozygous carrier
state for beta-thalassemia. The vast majority of adult
cases with beta thalassemia minor are asymptomatic,
some may have a normal to slightly reduced
hemoglobin level, microcytosis and hypochromia [13].
Thalassemias can now be diagnosed not only by
conventional clinical and blood testing, but also using
molecular technologies. These tests allow accurate
diagnosis to be made [9].
MATERIALS AND METHODS
We report a case with a rare association between
Turner phenotype and beta thalassemia minor. The
subject, a 22 years old caucasian female presented in
our departments for evaluation and counseling. The
history of the subject reveals that she is the first child,
born from non consanguineous parents. Her medical
h i s t o r y r e v e a l e d t h a t s h e w a s d i a g n o s e d w i t h ȕ
thalassemia minor during childhood, at that time
having mild anemia, with hypochromia and
microcytosis. Anemia began to develop within the first
months after birth. It became progressively more and
more severe. She presented recurrent hemolytic
episodes and repeated transfusions were needed.
Physical examination was initially apparently
remarkable only for splenomegaly. Splenectomy was
needed, which also decreased transfusion requirements.
Growth failure was not diagnosed until midteens, when
together with the absence of secondary sex
characteristics and primary amenorrhea raised the
suspicion of Turner syndrome. Detailed family history
was  taken  and  the  only  remarkable  element  was  that
her mother was a silent ȕ thalassemia carrier.
RESULTS
Clinical and functional evaluation of the case
revealed:
x Clinical features:
¾ Height: 150 cm
¾ Webbed neck,
¾ Broad chest
¾ Widespread nipples
¾ Liver: 4 cm under costal margin
¾ Hypoplastic nails
¾ Lack of secondary sexual characteristics
x Hormonal measurements:
¾ Low FSH: 0.7 mUI/ml (may be explained by
deposit of iron in hypophyse due to repeted
transfusions).
Turner syndrome clinical diagnosis was confirmed
by the cytogenetic analysis, which revealed the
presence of only one X chromosome (Fig. 1).
Chromosomal investigation was performed by
conventional G-banding technique, completed by
fluorescence insitu hybridization (FISH), which was
done on interphase cells and on metaphase
chromosomes. Karyotype was 45, X. FISH technique
Figure 1. Metaphase revealing 45 chromosomes, with only one X
chromosome (100x).
Figure 2. Metaphase and nuclei analyzed by FISH technique using
CEP X probe Spectrum Green- Abbott – Vysis, revealing
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was performed using CEP X probe Spectrum Green-
Abbott - Vysis, and a number of 50 metaphases and
200 nuclei were analyzed, all revealing the presence of
only one signal specific for the X chromosome (Fig. 2).
This allowed us to consider that the subject has an
homogeneous X monosomy.
Treatment may include human growth hormone and
estrogen replacement therapy. Estrogen replacement
was used to spur growth of secondary sexual
characteristics and also for maintaining bone integrity
and tissue health.
Thalassemia minor usually presents as an
asymptomatic mild microcytic anemia, but our patient
also had splenomegaly and required splenectomy.
Cases with Turner syndrome should be referred to
cardiology, urology, audiology and endocrinology,
because of the possible presence of congenital heart
diseases, hypertension, urological problems,
sensorineural hearing loss or hypothyroidism as well as
for the treatment of gonadal dysgenesis.
DISCUSSIONS
In 1938 Turner reported sexual infantilism, short
stature, webbed neck, cubitus valgus and primary
amenorrhea, all present in seven female cases [5]. Later
in 1954, it was observed that the ovaries were replaced
by streaks of stroma without follicles. Only one X
chromosome was demonstrated cytogenetically in these
subjects in 1959. There is a vigorous prenatal selection
against chromosome aberrations. About 99% of 45,X
fetuses are aborted spontaneously predominantly
during the first 12 weeks of gestation, due to severe
dysplasia of the lymphatic system and only 1% of these
fetuses survive to term. Despite this, Turner syndrome
is a relatively common chromosome disorder. It is
estimated that about 10% of all spontaneous abortuses
have a 45,X karyotype. Vast majority of Turner
syndrome cases lack the paternal sex chromosome, non
disjunction in male meiosis I accounting for 80% of
cases. This is the only known viable monosomy. In
general, abnormalities involving the sex chromosomes
are better tolerated than autosomal abnormalities
because only one X is active in the normal adults.
At birth Turner syndrome often manifests with
extensive edema. The edema in the neck and hands
results in neck webbing and arched nails. Turner
females are very short, sterile due to gonadal
dysgenesis, with primary amenorrhea, broad chests,
and usually have heart and kidney defects. In females
the lack of one of the X chromosomes can lead to total
sterility. It is prudent to rule out mosaicism with Y
chromosome material because of the increased risk for
gonadal blastoma [3].
Regarding the possible cytogenetic findings it is
estimated that 50% of affected females are 45, X.,
about 25% have structural abnormalities such as
isochromosome, ring chromosome or deletions of the p
or q arms. About 20% are mosaic: 45,X/46XX;
45,X/abnormal X; or 45,X/47,XXX and 4% of mosaic
cases were found to be XY conceptuses who lost the Y
in some cells and are: 45,X/46,XY. These females are
virilized at birth and at puberty and they have risk of
malignancy of the dysgenetic gonad, so it is
recommended that the gonads should be removed.
There are some controversies regarding the search for
the presence of Y chromosome material in some cases
of Turner syndrome. If this is present there is a high
risk of developing gonadoblastoma and dysgerminoma,
thus requiring preventive removal of the dysgenetic
gonads. In some cases identification of specific X and
Y sequences is important for establishing phenotype-
karyotype correlations and for adequate genetic
counseling. PCR may be needed in some instances to
identify the presence or absence of specific Y
sequences [16].
There are some karyotype-phenotype correlations,
s u c h a s : c a s e s w i t h 4 5 , X a r e m o r e l i k e l y t o h a v e
congenital lymphedema and webbing neck. Cases with
a mosaic condition may have secondary amenorheea
compared to those with homogeneous X monosomy
[10].
In Turner syndrome there is a haploinsufficiency
for the SHOX gene, placed on the pseudoautosomal
region of both X and Y (Xp22 and Yp11.3), therefore,
affected individuals have short stature and skeletal
manifestations. The long arm of the X chromosome has
genes for both ovarian development and maintenance.
Turner females have oocytes during fetal life but they
degenerate. It is believed that two functional X
chromosomes are needed for normal ovarian
development during fetal life.
Genetic counseling provides information about
recurrence risk or availability of prenatal diagnosis.
Primary amenorrheea, secondary amenorrheea, early
onset of menopause can indicate a chromosomal
abnormality, most frequently loss of one of the two X
chromosomes. Chromosome analysis would detect the
changes. During the last years, fluorescence in situ
hybridisation (FISH) has allowed to extent the
detectability of chromosome aberrations to the
submicroscopic level, especially for deletions [6].
Management of the disorder must also take into
consideration psychosocial counseling especially
regarding short stature which becomes a major concern
when entering school and pubertal failure and sterility
[8]. Growth retardation, characteristic for Turner
syndrome, is frequently severe in cases with
thalassemia. This retardation is caused, in part, by the
diversion of caloric resources for erythropoesis, as well
as by the chronic anemia. Estrogen replacement
therapy is needed not only to induce near normal
pubertal development, but also to prevent osteoporosis
and to reduce the risk of developing cardiovascular
disease [2]. It is important to understand that the less
severe phenotypes seen today do not exclude the
diagnosis, normal looking short girls should be closely
monitored. New approaches to cardiac evaluation were
suggested to strengthen the ability to detect and prevent
potentially life-threatening cardiac complications [11].
Defects in hemoglobin (Hb) involve qualitative as
well as quantitative alterations in globin physiology.
Beta thalassemia is due to impaired production of beta
globin chains, which leads to an excess of alpha globin
chains. These chains are unstable, incapable of forming
soluble tetramers on their own, and precipitate withinAnalele UniversităĠii din Oradea, Fascicula Biologie                                                                                                                                          Tom. XVI / 2, 2009, pp. 138-141
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the cell, thus leading to a variety of clinical
manifestations. The degree of alpha globin chain
excess determines the severity of clinical
manifestations, which are profound in homozygous
patients and less severe in heterozygotes, who
generally have minimal or mild anemia and no
symptoms [17]. These individuals are asymptomatic,
their condition often coming to light as an incidental
finding [7]. Risk factors for thalassemia include: Asian,
Chinese, Mediterranean, or African American
ethnicity, but also a positive family history of the
disorder. Genetic counseling and prenatal screening
may be available to those with a family history of this
condition who are planning to have children.
Sex chromosome anomalies and some single-gene
disorders may show phenotypic overlappings.
Cytogenetic investigation is absolutely necessary for
the evaluation of all patients with abnormal sexual
development or hypogonadism. Physicians should be
able to recognize the presenting signs and symptoms of
rare disorders and once the diagnosis is confirmed by a
chromosome or molecular analysis, they should be able
to serve as a valuable source of support for the index
case and family [15].
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